PRIME

Natural health product licensed in Canada

Other names

Prime Hormone Optimizer

Licence holder

Company 123

NPN or DIN-HM

80070570

Status

Active licence

Licence date

23 June 2016

Revision date

29 October 2019

Form

Capsule

Route of administration

Orale

Application type

Non traditionnelle

If this product were sold in France

• Conditions légales

  Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Tribulus terrestris L.: Les parties de plantes doivent être cuites

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Non-medicinal ingredients

Stéarate de magnésium, Acide stéarique, farine de riz, Silice, Gélatine

Recommended doses in Canada

Uses authorised in Canada

(DIM is a) Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effects of/the oxidative damage caused by/cell damage caused by) free radicals. (Zinc) Helps to maintain normal DNA synthesis. (Zinc) Helps in connective tissue formation. (Zinc) Helps to maintain healthy skin. (Zinc) Helps to maintain immune function. (Zinc) Helps in energy metabolism and tissue formation. (Zinc) Helps to maintain normal DNA synthesis. (Zinc) Helps to maintain normal acid-base metabolism. (Zinc) Helps to maintain healthy bones, hair, nail and/or skin. (DIM)Helps to support/promote healthy estrogen metabolism/balance. (Boron) Helps maintain healthy calcium metabolism. (Vitamin D) Helps in the development and maintenance of bones and teeth. (Vitamin D) Helps in the absorption and use of calcium and phosphorus (Vitamin D) Helps to build strong bones and teeth. (Vitamin D) Helps to maintain immune function. (Vitamin D) Helps in the process of normal cell division. (Togkat Ali Extract) Supports testosterone production; Helps promote testosterone production.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

• Précautions et mises en garde

  If you are taking any other medications or natural health products, consult a health care practitioner prior to use, as piperine may alter their effectiveness. If you are attempting to conceive, consult a health care practitioner prior to use. If you have a liver disorder or symptoms of low estrogen (such as joint pain, mood changes, changes in libido), consult a healthcare practitioner prior to use. If you develop liver-related symptoms (e.g. yellowing of the eyes and/or skin, dark urine, abdominal pain, jaundice) or symptoms of low estrogen, discontinue use and consult a health care practitioner. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. If you are taking antidepressants or blood thinners, consult a health care practitioner prior to use. If you have high blood pressure, consult a health care practitioner prior to use. If you have been diagnosed with estrogen-dependant cancer, consult a health care practitioner prior to use. If you have a kidney disorder, consult a health care practitioner prior to use. Consult a health care practitioner if you have benign prostate hypertrophy and/or prostate cancer. Consult a health care practitioner prior to use if you have been diagnosed with hypoactive sexual disorder, sexual dysfunction or erectile dysfunction. Consult a health care practitioner prior to use if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression. To exclude the diagnosis of a serious cause of hormonal imbalance, consult a health care practitioner prior to use.

• Effets indésirables connus

  Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Diuretic effect may occur.

Source

Official Health Canada record, licence 80070570

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 29 October 2019 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.